|
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'25 | $7.33 | $7.70 | +5.1% |
| Q4'24 | $6.27 | $6.19 | -1.2% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'25 | $829M | $790M | -4.7% |
| Q4'24 | - | $736M | - |
Market Data
UTHR is currently trading at $567.04, giving UTHR a market cap of 20.71B and a P/E ratio of 16.3. Today's range spans $471.00–$484.98, with shares opening at $478.90 and moving up $0.00 (0.0%) from the prior close. DailyIQ's technical score sits at 50/100 (HOLD) with a news sentiment reading of 54/100.
Over the past year UTHR has traded between $266.98 and $519.99 - the current price is +112.4% off the 52-week low and +9.0% from the high.
Neither bulls nor bears have the upper hand on UTHR (UTHR) right now. Score: 50/100 (HOLD). Sentiment: neutral (54/100). Price: $567.04 (near 52-week highs). (P/E: 16.3) At 20.71B in Healthcare market cap, the 52-week range of $266.98–$519.99 is the relevant frame - where the stock sits within that range, and whether volume confirms any directional move, matters more than the HOLD label alone.
In neutral phases, large-cap Healthcare names like UTHR are often where sector rotation debates play out quietly — at 20.71B in capitalization, the stock receives incremental allocation from funds reducing mega-cap exposure without the volatility of a small-cap entry. The 50/100 (HOLD) and neutral sentiment (54/100) at $567.04 (near 52-week highs) describe a stock that is being considered rather than avoided.
Most recent articles, ranked by recency (click to expand).
Sentiment gathered from recent headlines